Your browser doesn't support javascript.
loading
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300.
Rosales, Mauro; Pérez, George V; Ramón, Ailyn C; Cruz, Yiliam; Rodríguez-Ulloa, Arielis; Besada, Vladimir; Ramos, Yassel; Vázquez-Blomquist, Dania; Caballero, Evelin; Aguilar, Daylen; González, Luis J; Zettl, Katharina; Wisniewski, Jacek R; Yang, Ke; Perera, Yasser; Perea, Silvio E.
Affiliation
  • Rosales M; Department of Animal and Human Biology, Faculty of Biology, University of Havana (UH), Havana 10400, Cuba.
  • Pérez GV; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
  • Ramón AC; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
  • Cruz Y; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
  • Rodríguez-Ulloa A; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
  • Besada V; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana 10600, Cuba.
  • Ramos Y; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana 10600, Cuba.
  • Vázquez-Blomquist D; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana 10600, Cuba.
  • Caballero E; Pharmacogenomic Group, Department of System Biology, Biomedical Research Division, CIGB, Havana 10600, Cuba.
  • Aguilar D; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
  • González LJ; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
  • Zettl K; Mass Spectrometry Laboratory, Proteomics Group, Department of System Biology, Biomedical Research Division, CIGB, Havana 10600, Cuba.
  • Wisniewski JR; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, 82152 Munich, Germany.
  • Yang K; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, 82152 Munich, Germany.
  • Perera Y; China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Yongzhou Zhong Gu Biotechnology, Yongzhou City 425000, China.
  • Perea SE; Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba.
Biomedicines ; 9(7)2021 Jul 01.
Article in En | MEDLINE | ID: mdl-34356831

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomedicines Year: 2021 Type: Article Affiliation country: Cuba

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomedicines Year: 2021 Type: Article Affiliation country: Cuba